Fibrocell Science, Inc. Convertible Debt, Fair Value Disclosures
Fibrocell Science, Inc. had Convertible Debt, Fair Value Disclosures of $18.60 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:ConvertibleDebtFairValueDisclosures · last filed 2019-11-14
- 2019-09-30: Convertible Debt, Fair Value Disclosures $18.60M.
- 2019-06-30: Convertible Debt, Fair Value Disclosures $16.90M.
- 2019-03-31: Convertible Debt, Fair Value Disclosures $14.70M.
- 2018-12-31: Convertible Debt, Fair Value Disclosures $12.50M.
| Period end | Convertible Debt, Fair Value Disclosures |
|---|---|
| 2019-09-30 | $18.60M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $16.90M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $14.70M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $12.50M 10-K · filed 2019-03-27 |
| 2018-09-30 | $14.60M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $13.70M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $11.90M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $11.20M 10-K · filed 2019-03-27 |
| 2017-09-30 | $20.70M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $24.30M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $14.90M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $13.90M 10-K · filed 2018-03-19 |
| 2016-09-30 | $14.80M 10-Q · filed 2016-11-03 |